• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2021 Fiscal Year Final Research Report

Development of synthetic pathways and syntheses of natural products applicable to novel biological activity evaluation research

Research Project

  • PDF
Project/Area Number 19K06981
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 47010:Pharmaceutical chemistry and drug development sciences-related
Research InstitutionHoshi University

Principal Investigator

Sugita Kazuyuki  星薬科大学, 薬学部, 教授 (60542090)

Project Period (FY) 2019-04-01 – 2022-03-31
Keywords天然有機化合物 / 全合成 / caseabalansin A / hapromintrin B / mollolide A / cochlearol B / parvistemonine A / lamellodysidine A
Outline of Final Research Achievements

The total synthesis of caseabalansin A, that possesses a tetracyclic nucleus was achieved. Since the total synthesis of caseabalansin A was completed early, we conducted synthetic studies on cochlearol B with a pentacyclic skeleton, parvistemonine A with a tricyclic skeleton, corallocin A with a benzofuran skeleton, and lamellodysidine A with a tetracyclic skeleton. As a result of the implementation, synthetic pathways of these four natural products were established as well.
For hapromintrin B, which has a hexacyclic skeleton, we have succeeded in the construction of the tetracyclic skeleton so far. Currently, we are continuing to develop a synthetic pathway for hapromintrin B, including a geminal dimethyl units. For mollolide A, which has a bicyclo [3.2.1] octane ring, we succeeded in synthesizing the core skeleton. In addition, we are conducting the synthesis in optically active form and the improvement of synthetic yields, to furnish total synthesis.

Free Research Field

有機合成化学

Academic Significance and Societal Importance of the Research Achievements

本研究において全合成経路を確立したcaseabalansin A、cochlearol B、parvistemonine A、corallocin Aおよびlamellodysidine A、そして合成検討中のhapromintrin Bおよびmollolide Aは、それぞれ全く異なる骨格を有している。いずれの全合成経路も、短工程、高収率であり、創薬化学研究への適用が可能と考えられる。本研究において開発した合成経路を利用して誘導体合成を実施し、標的タンパク質の、新規モジュレーターが見出されることを期待している。また、開発した合成手法が、有機合成化学の進展に寄与するものと考えられる。

URL: 

Published: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi